By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Millipore today said that its shareholders have voted in favor of the firm's acquisition by Germany's Merck KGaA.

The Billerica, Mass.-based research products firm said that shareholders representing around 79 percent of its shares voted, with 98 percent voting in favor of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.